Similarly, the downregulation of FBLN2 leads to the migration and invasion of breast cancer cells [138], while the binding of FBLN2 to the β chain of the integrin receptors promotes the growth of colorectal carcinoma [139]. The gene discussed is FBLN2; the disease is breast carcinoma.